ATLANTA and SAN DIEGO, October 11, 2022 /PRNewswire/ — Mikart, LLC (“Mikart”), a full-service contract design and manufacturing company, announced that it has entered into a collaboration agreement with Nano PharmaSolutions, Inc. (“NPS”), an innovative nanotechnology company that has a proprietary NanoTransformer , ™ which improves the solubility of active pharmaceutical ingredients (API).
Nazar ElkarimPhD, Vice President of Pharmaceutical Development Services at Mikart, commented, “We are excited to bring this new technology from the pre-clinical phase to a clinical-stage GMP manufacturing environment. This differentiated, solvent-free nanogranulation process for drug development and manufacturing offers our customers an alternative solubility-enhancing technology.”
Kay OlmstattPhD/MBA, Chief Executive Officer at NPS added, “Nano PharmaSolutions is excited about this collaboration which will provide us with GMP manufacturing capabilities for nanomedicine development using our NanoTransformer™ technology at Mikart’s facility.”
Ludwig WeberVice President of Business Development at Mikart, added, “Mikart is committed to providing our customers with innovative options to improve solubility and bioavailability. We believe this nanotechnology will further enhance our developmental, clinical and commercial capabilities to add value to our growing customer base.”
About Mikart, LLC
Mikart, LLC is a privately held contract development and manufacturing organization (CDMO) founded in 1975. Mikart focuses on small molecule, potent compounds, solid oral products, combination products, suspensions, liquids and bulk packaging services. The company has a full range of formulation, analysis, packaging and manufacturing services with a seamless development solution that minimizes time to market from clinical work to commercial delivery. Follow us on LinkedIn to stay up to date https://www.linkedin.com/company/mikart-llc/mycompany/ or visit us at https://www.mikart.com/ for more information.
About Nano PharmaSolutions, Inc.
Nano PharmaSolutions, Inc. has developed a NanoTransformer™ technology that creates nanoparticles of active pharmaceutical ingredients using physical vapor deposition (PVD), a nanocoating method that does not use polymers or solvents. This robust high drug loading technology increases the bioavailability of poorly soluble drugs. NanoTransformer™ technology produces patient-centric dosage forms and accelerates drug candidates into the clinic by reducing development time and R&D costs. Follow us on LinkedIn to stay up to date https://www.linkedin.com/company/nano-pharmasolutions-inc/ or visit us at https://nanopharmasolutions.com/ for more information.
View original content to download multimedia: https://www.prnewswire.com/news-releases/mikart-and-nano-pharmasolutions-have-entered-into-a-collaboration-agreement-to-manufacture-clinical -trial-materials-with-nanotransformer-technology-301645380.html
SOURCE Mikart, LLC